LL-37 is the only human cathelicidin-derived antimicrobial peptide, a 37-residue amphipathic helix released from the hCAP18 precursor. It sits at the intersection of innate immunity and tissue repair research. This catalog entry is intended to support controlled in-vitro investigation and analytical comparison.
Laboratory Product Details:
-
Purity: ≥99% (HPLC Verified)
-
Form: Lyophilized Powder
- Presentation: One vial containing 5mg
-
Storage: Store at -20°C or lower
-
Usage: Laboratory research use only
Areas of Research Interest:
LL-37 is widely used in work on:
- Bacterial membrane disruption assays
- Innate immune response modelling
- Biofilm formation and inhibition
- Wound healing and keratinocyte migration
Research-use notice: Royal Peptides UK supplies this material exclusively for controlled in-vitro laboratory research. It is not for human or animal use.